Screener
Jazz Pharmaceuticals JAZZ FX & Other Adjustments
FX & Other Adjustments at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.
The source filing: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001232524-26-000025
FAQ
- What is Jazz Pharmaceuticals's FX & other adjustments?
- Jazz Pharmaceuticals (JAZZ) reported FX & other adjustments of -$24.3M in Q1 2026.
- How has Jazz Pharmaceuticals's FX & other adjustments changed year-over-year?
- Jazz Pharmaceuticals's FX & other adjustments decreased by 155.6% year-over-year, from $43.72M to -$24.3M.
- What does FX & other adjustments mean?
- Gains or losses resulting from the translation of financial statements of foreign subsidiaries into the reporting currency. This reflects the impact of exchange rate fluctuations on the value of international assets and liabilities.
Ask your AI about Jazz Pharmaceuticals's fx & other adjustments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude